Trial site
Kangwon National University Hospital
- 15running trials
- 7closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease11 trials
- Stroke3 trials
- Atrial fibrillation2 trials
- Type 2 diabetes2 trials
- Ulcerative colitis2 trials
- Antiphospholipid syndrome1 trial
- Crohn's disease1 trial
- IgA nephropathy1 trial
- Lupus (SLE)1 trial
- Nephrotic syndrome1 trial
- Peripheral artery disease1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 35 trials
- Phase 43 trials
- Status
- Recruiting10 trials
- Completed7 trials
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Seoul National University Hospital4 trials
- Asan Medical Center2 trials
- Eli Lilly and Company2 trials
- Janssen Research & Development, LLC2 trials
- Seung-Jung Park2 trials
- and 10 more
Running trials
Recruiting
Not yet recruiting
Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment
Recruiting
Recruiting
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
Recruiting
Recruiting
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Recruiting
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease8 recruiting
- Stroke2 recruiting
- IgA nephropathy1 recruiting
- Lupus (SLE)1 recruiting
- Nephrotic syndrome1 recruiting
- Rheumatoid arthritis1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026